Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jennifer Grosjean"'
Autor:
Antoine Martin, Stéphane de Botton, Geneviève Le Roux, Simone Boehrer, Claude Gardin, Thorsten Braun, Lorenzo Galluzzi, Guido Kroemer, Lionel Ades, Claire Fabre, Pierre Fenaux, Jennifer Grosjean
Publikováno v:
Blood. 111:2170-2180
Erlotinib, an inhibitor of the epidermal growth factor receptor (EGFR), induces differentiation, cell-cycle arrest, and apoptosis of EGFR-negative myeloblasts of patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), as well a
Publikováno v:
Biochemical and Biophysical Research Communications. 340:984-994
Angiogenesis is the development of blood capillaries from pre-existing vessels. Vascular endothelial growth factor (VEGF) is a key regulator of vessel growth and regression, and acts as an endothelial survival factor by protecting endothelial cells f
Autor:
Stéphane de Botton, Simone Boehrer, Guido Kroemer, Lionel Ades, Claire Fabre, Jennifer Grosjean-Raillard, Maximilien Tailler, Pierre Fenaux, Alain Israël, Thorsten Braun
Publikováno v:
Apoptosis. 20:1666-1667
High-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are characterized by the activation of the anti-apoptotic transcription factor NFκB, via the IKK complex. Here, we show that constitutive activation of the receptor tyrosine k
Autor:
Jennifer Grosjean-Raillard, Lionel Adès, Simone Boehrer, Maximilien Tailler, Claire Fabre, Thorsten Braun, Stéphane De Botton, Alain Israel, Pierre Fenaux, Guido Kroemer
Publikováno v:
Apoptosis : an international journal on programmed cell death. 13(9)
High-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are characterized by the activation of the anti-apoptotic transcription factor NFkappaB, via the IKK complex. Here, we show that constitutive activation of the receptor tyrosin
Autor:
Stéphane de Botton, Maximilien Tailler, Simone Boehrer, Lionel Ades, Claire Fabre, Jean-Luc Perfettini, Guido Kroemer, Pierre Fenaux, Jennifer Grosjean
Publikováno v:
Cell cycle (Georgetown, Tex.). 7(14)
Malignant myeloblasts arising in high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are characterized by the constitutive activation of the anti-apoptotic transcription factor NFkappaB. We found that DNA methyltransferase (DNMT
Autor:
Jennifer Grosjean, C. Fabre, Pierre Fenaux, Gabrielle Carvalho, Guido Kroemer, Lionel Ades, Najet Debili, Simone Boehrer, Thorsten Braun
Publikováno v:
Apoptosis : an international journal on programmed cell death. 12(6)
Myelodysplastic syndromes (MDS) constitute a preneoplastic condition in which potentially malignant cancer stem cells continuously die during differentiation. This MDS-associated cell death often involves caspase-3 activation, yet can also occur with
Autor:
Farisa Syeda, Caroline P.D. Wheeler-Jones, Rosemary J. Keogh, Ewa M. Paleolog, Jennifer Grosjean, Tom Carter, Rebecca A. Houliston
Publikováno v:
The Journal of biological chemistry. 281(17)
The functional significance of protease-activated receptors (PARs) in endothelial cells is largely undefined, and the intracellular consequences of their activation are poorly understood. Here, we show that the serine protease thrombin, a PAR-1-selec
Publikováno v:
Blood. 110:2434-2434
High-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are characterized by the constitutive activation of the anti-apoptotic transcription factor NF-kappaB, via the activation of the IKK complex. We show that constitutive activati
Autor:
Guido Kroemer, Lionel Ades, Claire Fabre, Pierre Fenaux, Antoine Martin, Thorsten Braun, Simone Boehrer, Jennifer Grosjean, Lorenzo Galluzzi, Claude Gardin, Geneviève Le Roux, Stéphane de Botton
Publikováno v:
Blood. 110:399-399
Background: The EGFR-inhibitor erlotinib was designed to antagonize the deregulated EGFR-activity in solid tumors. After showing that the EGFR-inhibitor erlotinib induces apoptosis in EGFR-negative ex vivo cells of patients with MDS and AML while spa
Autor:
Guido Kroemer, Lorenzo Galluzzi, Ken A. Olaussen, Pierre Fenaux, Thorsten Braun, Simone Boehrer, Stéphane de Botton, Lionel Ades, Claire Fabre, Jennifer Grosjean
Publikováno v:
Blood. 110:2438-2438
Background: Findings, that activation of the DDR-pathway in preneoplastic lesions of solid neoplasms slows tumorigenesis, could also underly progression of MDS to AML. We previously showed (ASH 2006, abstr n° 2649), that - in contrast to the de novo